Acetic Acid
CAS 64-19-7
Acetic Acid (CAS 64-19-7) is a Phase 4 pharmaceutical compound with 4 bioactivity targets and 41 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | EC50 | 38.3 ug.mL-1 | 3 | - |
| - | Kd | 946.6666666666666 nM | 2 | - |
| - | EC50 | 12000 nM | 1 | - |
| Tyrosine-protein kinase Lck Kinase |
Kd | 6.19 | - | Homo sapiens |
| Tyrosine-protein kinase Fyn Kinase |
Kd | 6.05 | - | Homo sapiens |
| Free fatty acid receptor 2 GPCR |
EC50 | 4.6 | - | Homo sapiens |
| Free fatty acid receptor 3 GPCR |
EC50 | 4.92 | - | Homo sapiens |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Chemical burn | 5 | 21.822 | 10008420 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| FFA2 receptor FFAR2 |
Full agonist | 3.0999999046325684 pEC50 | 12496283|12684041|12711604|21220428 |
| FFA3 receptor FFAR3 |
Full agonist | 2.799999952316284 pEC50 | 12496283|12711604|14722361|21220428 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Acetic acid | 168 | SU | MTHSPL |
| Acetic Acid | 168 | SU | MTHSPL |
| acetic acid | 168 | SU | MTHSPL |
| ACETIC ACID | 168 | SU | MTHSPL |
| acetic acid | 168 | IN | RXNORM |
Side Effects
SIDER side-effect terms mapped to the drug or same-CAS compound identity.
| Side Effect | Drug Name | MedDRA Type | Concept ID |
|---|---|---|---|
| Acidosis | acetate | LLT | C0001122 |
| Acidosis | acetate | PT | C0001122 |
| Haematuria | acetate | LLT | C0018965 |
| Haematuria | acetate | PT | C0018965 |
| Hypernatraemia | acetate | LLT | C0020488 |
| Hypernatraemia | acetate | PT | C0020488 |
| Pain | acetate | LLT | C0030193 |
| Pain | acetate | PT | C0030193 |
| Pain | acetate | PT | C0030193 |
| Stinging | acetate | LLT | C0677500 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Acetic Acid used for in pharmaceutical contexts?
Acetic Acid (CAS 64-19-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Acetic Acid?
Acetic Acid has 41 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Chemical burn, Atrial fibrillation, Brain natriuretic peptide increased, Bronchospasm, Cardiac disorder. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Acetic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Acetic Acid — Deep Research Profile with EU status "permitted".
What clinical phase is Acetic Acid in?
Acetic Acid is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Acetic Acid?
Acetic Acid has 7 bioactivity rows in this page query. Rendered target entries include Tyrosine-protein kinase Lck, Tyrosine-protein kinase Fyn, Free fatty acid receptor 2, Free fatty acid receptor 3.